Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-983-0 | CAS number: 90-30-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.08 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- LOAEL
- Value:
- 5 mg/kg bw/day
- Modified dose descriptor starting point:
- LOAEC
- Value:
- 24.5 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Due to lack of repeated dose toxicity data by the inhalation route, a route to route extrapolation was performed. The LOAEL (oral) derived in the sub-chronic oral toxicity study in rats is converted into a LOAEC (corrected) in accordance to guidance on information requirements and chemical safety assessment, Chapter R.8, ECHA, May 2008. For this purpose a default body weight of 70 kg and a respiratory volume of 10 m3/d are applied.
An oral absorption of 100% is expected for N-phenyl-1-naphthylamine since the substance is well absorbed after ingestion and readily excreted. Nevertheless, for the oral-to-inhalation extrapolation, following a worst-case assumption and to account for uncertainties an additional assessment factor of 2 was used to consider the different absorption properties of the respiratory tract and after oral intake in accordance with ECHA Guidance R.8.
Also, to account for differences in experimental and worker exposure conditions (rats: 7 d/week; workers: 5 d/week) a factor of 7/5 was applied as well.
LOAECcorr = 5 mg/kg bw/d x 70 kg / 10 m3/d / 2 x (7 d/week / 5 d/week) = 24.5 mg/m3
- AF for dose response relationship:
- 3
- Justification:
- default for extrapolation of the LOAEL to the NAEL
- AF for differences in duration of exposure:
- 2
- Justification:
- extrapolation from subchronic to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- default for allometric scaling from rat to human
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 5
- Justification:
- standard factor for worker
- AF for the quality of the whole database:
- 1
- Justification:
- GLP and guideline compliant study
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 44 mg/m³
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 125
- Dose descriptor starting point:
- NOAEL
- Value:
- 200 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 5 583 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Since no acute studies by inhalation are available, a route to route extrapolation is performed with data from oral application.
The following acute oral toxicity studies are available:
MacEwen, J. D. and Vernot, E. H., 1974 Ciba-Geigy, 1987 Weil, 1974 Bayer, 1978 test animal SD rats, male rats, male and female Wistar rats, male Wistar rats, female Dose levels 500, 1000, 2000, 4000 mg/kg 200, 2000 mg/kg 1000, 2000 and 4000 mg/kg bw 5000 mg/kg LD50 combined - > 200 - < 2000 mg/kg 2380 mg/kg LD50 males 1625 mg/kg 2000 mg/kg LD50 females - > 200 - < 2000 mg/kg > 5000 mg/kg LD0 males 1000 mg/kg 200 mg/kg 1000 mg/kg bw LD0 females - 200 mg/kg - Pathology no data no effects noted at 200 mg/kg livers mottled; stomachs transparent, free blood; kidneys and adrenals congested; intestines injected, free blood and distended; dose levels not specified. no data Identification of the point of departure:
The lowest, therefore most conservative no effect value is the LD0 of 200 mg/kg in both male and female rats based on the study by Ciba-Geigy. This value is considered suitable since no deaths and no systemic effects have been reported at this dose level. This value is considered to be the NOAEL.
DNEL derivation
The LD0 (=NOAEL) of 200 mg/kg body weight observed in male and female rats is the starting point for DNEL derivation. Following a rout to route extrapolation approach, this oral NOAEL needs to be transformed into an inhalatory NOAEC considering the respiratory volume of the rat.
The standard respiratory volume of the rat is 0.2 l/min. Considering a short term exposure of 15 min, the total respiratory volume of a rat during 15 minutes is 0.2 l/min x 15 min = 3 l = 0.003 m3. Based on the average rat body weight (0.25 kg) this translates into 0.012 m3/kg body weight.
The atmospheric concentration yielding a dose equivalent to 200 mg/kg orally after 15 min of breathing is therefore calculated as 200 mg/kg / 0.012 m3/kg = 16666 mg/m3. To correct this value for human workers, further modifications are required taking the increased respiratory volume of workers into account compared to humans in rest. This is achieved by multiplication with a factor of 0.67.
An oral absorption of 100% is expected for N-phenyl-1-naphthylamine since the substance is well absorbed after ingestion and readily excreted. Nevertheless, for the oral-to-inhalation extrapolation, following a worst-case assumption and to account for uncertainties an additional assessment factor of 2 was used to consider the different absorption properties of the respiratory tract and after oral intake in accordance with ECHA Guidance R.8.
16666 mg/m3x 0.67 / 2 = 5583 mg/m3. This value is considered the NOAECcorr.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is part of the route to route extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 5
- Justification:
- standard factor for worker
- AF for the quality of the whole database:
- 1
- Justification:
- The data base is considered sufficient and a worst case approach was followed, using the most sensitve result available.
- AF for remaining uncertainties:
- 10
- Justification:
- uncertainties in regard of route to route extrapolation
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.02 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- LOAEL
- Value:
- 5 mg/kg bw/day
- Modified dose descriptor starting point:
- LOAEL
- Value:
- 7 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Route-to-route extrapolation is needed from the oral to the dermal route. Due to differences in experimental and worker exposure conditions (rats: 7 d/week; worker: 5 d/week) a factor of 7/5 is applied to the LOAEL.
Also, it is assumed that dermal absorption will not be higher than the oral absorption (100%). Hence, no additional assessment factor was used according to REACH Guidance R.8.
LOAELcorr = 5 mg/kg bw/d x (7 d/week / 5 d/week) = 7 mg/kg bw/d
However, the dermal absorption of the pure substance and relevant in-use concentrations were determined in a dermal absorption study. The derived percentages are not used to derive the dermal DNEL. They are directly applied to the exposure estimates instead. Please refer to section 9 of the CSR.
- AF for dose response relationship:
- 3
- Justification:
- default for extrapolation of the LOAEL to the NAEL
- AF for differences in duration of exposure:
- 2
- Justification:
- extrapolation from subchronic to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- extrapolation from rat to human
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 5
- Justification:
- standard factor for worker
- AF for the quality of the whole database:
- 1
- Justification:
- GLP-compliant guideline study
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6.67 mg/kg bw/day
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Dermal
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- LOAEL
- Value:
- 2 000 mg/kg bw/day
- Modified dose descriptor starting point:
- LOAEL
- Value:
- 2 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Available acute dermal toxicity study:
Weil, 1974
test animal
male rabbits
Dose levels
2000 and 8000 mg/kg bw
LD50 males
> 5000 mg/kg. One animal died at 8000 mg/kg
LD0 males
2000 mg/kg bw
Pathology
Livers congested and mottled; spleens dark; kidneys khaki brown in color. Not specified at which dose level, therefore it is assumed to have occurred also at the 2000 mg/kg dose level
Identification of the point of departure:
The lowest applied dose level is 2000 mg/kg in male rabbits. Although no deaths occurred at this dose level, it is considered a LOAEL since it has to be assumed that histological findings were also recorded at this dose level. This LOAEL of 2000 mg/kg is used as starting point for DNEL calculations.
Additionally, the dermal absorption of the pure substance and relevant in-use concentrations were determined in a dermal absorption study. The derived percentages are not used to derive the dermal DNEL. They are directly applied to the exposure estimates instead. Please refer to section 9 of the CSR.
- AF for dose response relationship:
- 1
- Justification:
- The dose response is considered unremarkable.
- AF for interspecies differences (allometric scaling):
- 2.4
- Justification:
- extrapolation from rabbit to human
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 5
- Justification:
- standard factor for worker
- AF for the quality of the whole database:
- 1
- Justification:
- The data base is considered sufficient.
- AF for remaining uncertainties:
- 10
- Justification:
- remaining uncertainties for using a LOAEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.015 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- LOAEL
- Value:
- 5 mg/kg bw/day
- Modified dose descriptor starting point:
- LOAEC
- Value:
- 2.17 mg/m³
- Explanation for the modification of the dose descriptor starting point:
As starting point the LOAEL resulting from a subchronic oral repeated dose toxicity study in rats (2016) is used.
Route-to-route extrapolation is needed from the oral to the inhalation route. In accordance with ECHA Guidance R.8 the LOAEL is divided by the respiratory volume accounting for 24 hours (1.15 mg/kg bw).
An oral absorption of 100% is expected for N-phenyl-1-naphthylamine since the substance is well absorbed after ingestion and readily excreted. Nevertheless, for the oral-to-inhalation extrapolation, following a worst-case assumption and to account for uncertainties an additional assessment factor of 2 was used to consider the different absorption properties of the respiratory tract and after oral intake in accordance with ECHA Guidance R.8.
LOAECcorr = 5 mg/kg bw/d / 1.15 m3/kg bw / 2 = 2.17 mg/m3
- AF for dose response relationship:
- 3
- Justification:
- default since the starting point is a LOAEL
- AF for differences in duration of exposure:
- 2
- Justification:
- extrapolation from subchronic to chronic
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is part of the route to route extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 10
- Justification:
- standard factor for the general population
- AF for the quality of the whole database:
- 1
- Justification:
- GLP and guideline compliant study
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 33 mg/m³
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 250
- Dose descriptor starting point:
- NOAEL
- Value:
- 200 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 8 333 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Since no acute studies by inhalation are available, a route to route extrapolation is performed with data from oral application.
The following acute oral toxicity studies are available:
MacEwen, J. D. and Vernot, E. H., 1974 Ciba-Geigy, 1987 Weil, 1974 Bayer, 1978 test animal SD rats, male rats, male and female Wistar rats, male Wistar rats, female Dose levels 500, 1000, 2000, 4000 mg/kg 200, 2000 mg/kg 1000, 2000 and 4000 mg/kg bw 5000 mg/kg LD50 combined - > 200 - < 2000 mg/kg 2380 mg/kg LD50 males 1625 mg/kg 2000 mg/kg LD50 females - > 200 - < 2000 mg/kg > 5000 mg/kg LD0 males 1000 mg/kg 200 mg/kg 1000 mg/kg bw LD0 females - 200 mg/kg - Pathology no data no effects noted at 200 mg/kg livers mottled; stomachs transparent, free blood; kidneys and adrenals congested; intestines injected, free blood and distended; dose levels not specified. no data Identification of the point of departure:
The lowest, therefore most conservative no effect value is the LD0 of 200 mg/kg in both male and female rats based on the study by Ciba-Geigy. This value is considered suitable since no deaths and no systemic effects have been reported at this dose level. This value is considered to be the NOAEL.
DNEL derivation
The LD0 (=NOAEL) of 200 mg/kg body weight observed in male and female rats is the starting point for DNEL derivation. Following a route to route extrapolation approach, this oral NOAEL needs to be transformed into an inhalatory NOAEC considering the respiratory volume of the rat.
The standard respiratory volume of the rat is 0.2 l/min. Considering a short term exposure of 15 min, the total respiratory volume of a rat during 15 minutes is 0.2 l/min x 15 min = 3 l = 0.003 m3. Based on the average rat body weight (0.25 kg) this translates into 0.012 m3/kg body weight.
The atmospheric concentration yielding a dose equivalent to 200 mg/kg orally after 15 min of breathing is therefore calculated as 200 mg/kg / 0.012 m3/kg = 16666 mg/m3.
An oral absorption of 100% is expected for N-phenyl-1-naphthylamine since the substance is well absorbed after ingestion and readily excreted. Nevertheless, for the oral-to-inhalation extrapolation, following a worst-case assumption and to account for uncertainties an additional assessment factor of 2 was used to consider the different absorption properties of the respiratory tract and after oral intake in accordance with ECHA Guidance R.8.
16666 mg/m3 /2 = 8333 mg/m3. This value is considered the NOAECcorr.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is part of the route to route extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 10
- Justification:
- standard factor for the general population
- AF for the quality of the whole database:
- 1
- Justification:
- The data base is considered sufficient and a worst case approach was followed, using the most sensitve result available.
- AF for remaining uncertainties:
- 10
- Justification:
- uncertainties in regard of route to route extrapolation
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.008 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- LOAEL
- Value:
- 5 mg/kg bw/day
- Modified dose descriptor starting point:
- LOAEL
- Value:
- 5 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
As starting point the LOAEL resulting from a subchronic oral repeated dose toxicity study in rats (2016) is used.
Route-to-route extrapolation is needed from the oral to the dermal route. In accordance with ECHA Guidance R.8 it is assumed that dermal absorption will not exceed the oral absorption (100%). Hence, no additional assessment factor was used according to REACH Guidance R.8.
However, the dermal absorption of the pure substance and relevant in-use concentrations were determined in a dermal absorption study. The derived percentages are not used to derive the dermal DNEL.They are directly applied to the exposure estimates instead.
- AF for dose response relationship:
- 3
- Justification:
- default as the starting point for the DNEL derivation is a LOAEL
- AF for differences in duration of exposure:
- 2
- Justification:
- extrapolation from subchronic to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- extrapolation from rat to human
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 10
- Justification:
- standard factor for the general population
- AF for the quality of the whole database:
- 1
- Justification:
- GLP-compliant guideline study
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.33 mg/kg bw/day
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Dermal
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- LOAEL
- Value:
- 2 000 mg/kg bw/day
- Modified dose descriptor starting point:
- LOAEL
- Value:
- 2 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Available acute dermal toxicity study:
Weil, 1974
test animal
male rabbits
Dose levels
2000 and 8000 mg/kg bw
LD50 males
> 5000 mg/kg. One animal died at 8000 mg/kg
LD0 males
2000 mg/kg bw
Pathology
Livers congested and mottled; spleens dark; kidneys khaki brown in color. Not specified at which dose level, therefore it is assumed to have occurred also at the 2000 mg/kg dose level
Identification of the point of departure:
The lowest applied dose level is 2000 mg/kg in male rabbits. Although no deaths occurred at this dose level, it is considered a LOAEL since it has to be assumed that histological findings were also recorded at this dose level. This LOAEL of 2000 mg/kg is used as starting point for DNEL calculations.
However, the dermal absorption of the pure substance and relevant in-use concentrations were determined in a dermal absorption study. The derived percentages are not used to derive the dermal DNEL. They are directly applied to the exposure estimates instead.
- AF for dose response relationship:
- 1
- Justification:
- The dose response is considered unremarkable.
- AF for interspecies differences (allometric scaling):
- 2.4
- Justification:
- extrapolation from rabbit to human
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 10
- Justification:
- standard factor for the general population
- AF for the quality of the whole database:
- 1
- Justification:
- The data base is considered sufficient.
- AF for remaining uncertainties:
- 10
- Justification:
- remaining uncertainties for using a LOAEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.008 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 5 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
As starting point the LOAEL obtained in an subchronic oral toxicity study in rats (2016) is used. No modification of the dose descriptor starting point is necessary.
- AF for dose response relationship:
- 3
- Justification:
- default as the starting point for the DNEL derivation is a LOAEL
- AF for differences in duration of exposure:
- 2
- Justification:
- extrapolation from subchronic to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- extrapolation from rat to human
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 10
- Justification:
- standard factor for the general population
- AF for the quality of the whole database:
- 1
- Justification:
- GLP-compliant guideline study
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/kg bw/day
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 200 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The following acute oral toxicity studies are available:
MacEwen, J. D. and Vernot, E. H., 1974 Ciba-Geigy, 1987 Weil, 1974 Bayer, 1978 test animal SD rats, male rats, male and female Wistar rats, male Wistar rats, female Dose levels 500, 1000, 2000, 4000 mg/kg 200, 2000 mg/kg 1000, 2000 and 4000 mg/kg bw 5000 mg/kg LD50 combined - > 200 - < 2000 mg/kg 2380 mg/kg LD50 males 1625 mg/kg 2000 mg/kg LD50 females - > 200 - < 2000 mg/kg > 5000 mg/kg LD0 males 1000 mg/kg 200 mg/kg 1000 mg/kg bw LD0 females - 200 mg/kg - Pathology no data no effects noted at 200 mg/kg livers mottled; stomachs transparent, free blood; kidneys and adrenals congested; intestines injected, free blood and distended; dose levels not specified. no data Identification of the point of departure:
The lowest, therefore most conservative no effect value is the LD0 of 200 mg/kg in both male and female rats based on the study by Ciba-Geigy. This value is considered suitable since no deaths and no systemic effects have been reported at this dose level. This value is considered to be the NOAEL.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rat to human (default)
- AF for other interspecies differences:
- 2.5
- Justification:
- standard factor for remaining uncertainties
- AF for intraspecies differences:
- 10
- Justification:
- standard factor for the general population
- AF for the quality of the whole database:
- 1
- Justification:
- The data base is considered sufficient and a worst case approach was followed, using the most sensitve result available.
- AF for remaining uncertainties:
- 1
- Justification:
- no remaining uncertainties
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)